The AHRQ’s report would include:
An assessment of existing research on neonatal abstinence syndrome;
An evaluation of the causes, and barriers to treatment, of opioid use disorders among women of reproductive age;
An evaluation of treatment for pregnant women with opioid use disorders and infants with neonatal abstinence syndrome;
Recommendations for preventing, identifying, and treating opioid dependency in women and neonatal abstinence syndrome.
The Dept. of Health and Human Services (HHS) would be required to review its current activities related to prenatal opioid use and neonatal abstinence syndrome. It would then develop a strategy to address gaps in research and programs that deal with these issues.
Also, the Centers for Disease Control and Prevention (CDC) would be required to provide technical assistance to states in order to improve neonatal abstinence syndrome tracking. That tracking data would be made available to the public.